Abstract

BackgroundCoxsackievirus A9 (CV-A9) is a pathogenic enterovirus type within the family Picornaviridae. CV-A9 infects A549 human epithelial lung carcinoma cells by attaching to the αVβ6 integrin receptor through a highly conserved Arg-Gly-Asp (RGD) motif, which is located at the exposed carboxy-terminus of the capsid protein VP1 detected in all studied clinical isolates. However, genetically-modified CV-A9 that lacks the RGD motif (CV-A9-RGDdel) has been shown to be infectious in some cell lines but not in A549, suggesting that RGD-mediated integrin binding is not always essential for efficient entry of CV-A9.MethodsTwo cell lines, A549 and SW480, were used in the study. SW480 was the study object for the integrin-independent entry and A549 was used as the control for integrin-dependent entry. Receptor levels were quantitated by cell sorting and quantitative PCR. Antibody blocking assay and siRNA silencing of receptor-encoding genes were used to block virus infection. Peptide phage display library was used to identify peptide binders to CV-A9. Immunofluorescence and confocal microscopy were used to visualize the virus infection in the cells.ResultsWe investigated the receptor use and early stages of CV-A9 internalization to SW480 human epithelial colon adenocarcinoma cells. Contrary to A549 infection, we showed that both CV-A9 and CV-A9-RGDdel internalized into SW480 cells and that function-blocking anti-αV integrin antibodies had no effect on the binding and entry of CV-A9. Whereas siRNA silencing of β6 integrin subunit had no influence on virus infection in SW480, silencing of β2-microglobulin (β2M) inhibited the virus infection in both cell lines. By using a peptide phage display screening, the virus-binding peptide identical to the N-terminal sequence of HSPA5 protein was identified and shown to block the virus infection in both A549 and SW480 cell lines. HSPA5 was also found to co-localize with CV-A9 at the SW480 cell periphery during the early stages of infection by confocal microscopy.ConclusionsThe data suggest that while αVβ6 integrin is essential for CV-A9 in A549 cell line, it is not required in SW480 cell line in which β2M and HSPA5 alone are sufficient for CV-A9 infection. This suggests that the choice of CV-A9 receptor(s) is dependent on the tissue/cellular environment.Electronic supplementary materialThe online version of this article (doi:10.1186/s12985-016-0619-y) contains supplementary material, which is available to authorized users.

Highlights

  • Coxsackievirus A9 (CV-A9) is a pathogenic enterovirus type within the family Picornaviridae

  • CV-A9 and genetically modified receptor through a highly conserved Arg-Gly-Asp (RGD)-deficient CV-A9 infect Human epithelial colon carcinoma (SW480) cells Previously, it has been shown that infection of CV-A9 into Human epithelial lung carcinoma (A549) cells is dependent on integrin αVβ6 [27]

  • To study CV-A9 infection in a cellular model in which αVβ6 is not expressed, we chose to use human colon adenocarcinoma cells (SW480) [20]. It was reported by plaque titration assay that CV-A9 infects SW480 cells only after transfection with the cDNA copy of the β6 integrin subunit and overexpression of the corresponding protein [14]

Read more

Summary

Introduction

Coxsackievirus A9 (CV-A9) is a pathogenic enterovirus type within the family Picornaviridae. CV-A9 infects A549 human epithelial lung carcinoma cells by attaching to the αVβ6 integrin receptor through a highly conserved Arg-Gly-Asp (RGD) motif, which is located at the exposed carboxy-terminus of the capsid protein VP1 detected in all studied clinical isolates. Coxsackievirus A9 (CV-A9) is an important member of Enterovirus B species (genus Enterovirus B, family Picornaviridae, http://www.picornastudygroup.com/) and one of the most prevalent and pathogenic enteroviruses [1, 3]. The virus particle is composed of four structural proteins (VP1-4). A specific feature of the CV-A9 VP1 capsid protein is the C-terminal Arg-Gly-Asp (RGD) tripeptide motif through which the virus interacts with αV integrins in vitro and on the cell surface [4, 6]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call